{"database": "open_comments", "table": "documents", "rows": [["FDA-2015-N-3469-0001", "FDA", "FDA-2015-N-3469", "Bulk Drug Substances That Can Be Used To Compound Drug Products in\nAccordance With Section 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket", "Notice", "Notice of Availability", "2015-10-27", 2015, 10, "2015-10-27", "2050-02-21", "2050-02-22 04:59:59", 1, "2026-08-11 09:00:50", "2015-27270", 1, 0, "0900006481cf17b1"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "comment_end_datetime", "perpetual_docket", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-N-3469-0001"], "units": {}, "query_ms": 0.2180099836550653, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}